# A Comparison of the Safety and Effectiveness of Two Forms of Patient-controlled Pain Medication Used After Total Hip Replacement: The E-TRANS Fentanyl Transdermal System Versus the Morphine Intravenous Pump

> **NCT00264485** · PHASE3 · COMPLETED · sponsor: **Alza Corporation, DE, USA** · enrollment: 799 (actual)

## Conditions studied

- Pain, Postoperative
- Analgesia

## Interventions

- **DRUG:** E-TRANS Fentanyl hydrochloride; Morphine

## Key facts

- **NCT ID:** NCT00264485
- **Lead sponsor:** Alza Corporation, DE, USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** 799 (ACTUAL)
- **Last updated:** 2011-05-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00264485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00264485, "A Comparison of the Safety and Effectiveness of Two Forms of Patient-controlled Pain Medication Used After Total Hip Replacement: The E-TRANS Fentanyl Transdermal System Versus the Morphine Intravenous Pump". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00264485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*